Abstract:Hepatitis C virus (HCV), the main cause of non-A, non-B hepatitis in the United States and possibly in the world, is believed to be transmitted primarily through parenteral exposure. Many screening and supplemental tests are available to detect antibodies to HCV in serum. The ability to use commercial assays to detect antibodies to HCV in urine was investigated in this study. A total of 229 serum/urine matched samples were collected sequentially from forensic autopsy cases examined at the Office of the Chief M… Show more
“…The correlation between EIA and Western Blot in urine samples was poor, suggesting that most EIA-positive results reflected a nonspecific false positive reaction. These results differ from those of Zhang et al [1994] who reported an excellent correlation of anti-HCV detection between serum and urine. However, their study was carried out using serum and urine samples obtained from forensic autopsy cases and there is a possibility that urine samples were mixed with serum.…”
Section: Discussioncontrasting
confidence: 85%
“…A correlation between serum antibodies and salivary or urinary antibodies has been reported in some viral infections, e.g., human immunodeficiency virus (HIV) [Archibald et al, 1986;Cao et al, 1989;Major et al, 1991;Crofts et al, 1991;Desai et al, 1991], hepatitis A virus (HAV) [Stuart et al, 1992;Parry et al, 1989], rubella [Saleh, 1991] and following immunization against polio virus [Zaman et al, 1991], rota virus [Ward et al, 1992;Friedman et al, 1993], and HAV [Hurni et al, 1993;Laufer et al, 1995]. As for HCV, oral fluid [Thieme et al, 1992;Sherman et al, 1994] and urine obtained from autopsy cases [Zhang et al, 1994] were suggested as alternative specimens for serum, for serodiagnosis of infection with this agent.…”
Infection with hepatitis C virus (HCV) is usually established by detection of serum antibodies (anti-HCV). This study was conducted in order to evaluate whether saliva and urine may substitute serum for anti-HCV detection. Serum, saliva, and urine were obtained simultaneously from 141 patients with a variety of liver diseases and from 52 patients with autoimmune diseases (systemic lupus erythematosus n = 27 and rheumatoid arthritis n = 25). The cell free fraction of saliva and urine samples was tested for anti-HCV using a modification of a serum anti-HCV kit. Western blot analysis was used as a confirmation method. Of the patients with liver diseases, 73 were anti-HCV-seropositive. Salivary and urinary anti-HCV could be detected in 66 (90%) and 36 (49%) of the anti-HCV-seropositive patients, respectively. The presence of anti-HCV in saliva or urine was not related to the severity of liver disease. All the anti-HCV-seronegative liver patients were negative for salivary anti-HCV and 22 (32%) had urinary anti-HCV. The patients with autoimmune diseases were all anti-HCV-seronegative. None had detectable salivary anti-HCV while 33 (63%) were positive for urinary anti-HCV. Western Blot analysis confirmed the presence of anti-HCV in all serum and saliva samples tested but only in 2/12 urine samples. The results suggest that saliva, but not urine, may serve as a substitute for serum for the determination of anti-HCV positivity.
“…The correlation between EIA and Western Blot in urine samples was poor, suggesting that most EIA-positive results reflected a nonspecific false positive reaction. These results differ from those of Zhang et al [1994] who reported an excellent correlation of anti-HCV detection between serum and urine. However, their study was carried out using serum and urine samples obtained from forensic autopsy cases and there is a possibility that urine samples were mixed with serum.…”
Section: Discussioncontrasting
confidence: 85%
“…A correlation between serum antibodies and salivary or urinary antibodies has been reported in some viral infections, e.g., human immunodeficiency virus (HIV) [Archibald et al, 1986;Cao et al, 1989;Major et al, 1991;Crofts et al, 1991;Desai et al, 1991], hepatitis A virus (HAV) [Stuart et al, 1992;Parry et al, 1989], rubella [Saleh, 1991] and following immunization against polio virus [Zaman et al, 1991], rota virus [Ward et al, 1992;Friedman et al, 1993], and HAV [Hurni et al, 1993;Laufer et al, 1995]. As for HCV, oral fluid [Thieme et al, 1992;Sherman et al, 1994] and urine obtained from autopsy cases [Zhang et al, 1994] were suggested as alternative specimens for serum, for serodiagnosis of infection with this agent.…”
Infection with hepatitis C virus (HCV) is usually established by detection of serum antibodies (anti-HCV). This study was conducted in order to evaluate whether saliva and urine may substitute serum for anti-HCV detection. Serum, saliva, and urine were obtained simultaneously from 141 patients with a variety of liver diseases and from 52 patients with autoimmune diseases (systemic lupus erythematosus n = 27 and rheumatoid arthritis n = 25). The cell free fraction of saliva and urine samples was tested for anti-HCV using a modification of a serum anti-HCV kit. Western blot analysis was used as a confirmation method. Of the patients with liver diseases, 73 were anti-HCV-seropositive. Salivary and urinary anti-HCV could be detected in 66 (90%) and 36 (49%) of the anti-HCV-seropositive patients, respectively. The presence of anti-HCV in saliva or urine was not related to the severity of liver disease. All the anti-HCV-seronegative liver patients were negative for salivary anti-HCV and 22 (32%) had urinary anti-HCV. The patients with autoimmune diseases were all anti-HCV-seronegative. None had detectable salivary anti-HCV while 33 (63%) were positive for urinary anti-HCV. Western Blot analysis confirmed the presence of anti-HCV in all serum and saliva samples tested but only in 2/12 urine samples. The results suggest that saliva, but not urine, may serve as a substitute for serum for the determination of anti-HCV positivity.
“…A correlation between serum antibodies and salivary or urinary antibodies has been reported in some viral infections, e.g., human immunodeficiency virus (HIV) [Archibald et al, 1986;Cao et al, 1989;Major et al, 1991;Crofts et al, 1991;Desai et al, 1991], hepatitis A virus (HAV) [Stuart et al, 1992;Parry et al, 1989], rubella [Saleh, 1991] and following immunization against polio virus [Zaman et al, 1991], rota virus [Ward et al, 1992;Friedman et al, 1993], and HAV [Hurni et al, 1993;Laufer et al, 1995]. As for HCV, oral fluid [Thieme et al, 1992;Sherman et al, 1994] and urine obtained from autopsy cases [Zhang et al, 1994] were suggested as alternative specimens for serum, for serodiagnosis of infection with this agent.…”
Infection with hepatitis C virus (HCV) is usually established by detection of serum antibodies (anti-HCV). This study was conducted in order to evaluate whether saliva and urine may substitute serum for anti-HCV detection. Serum, saliva, and urine were obtained simultaneously from 141 patients with a variety of liver diseases and from 52 patients with autoimmune diseases (systemic lupus erythematosus n = 27 and rheumatoid arthritis n = 25). The cell free fraction of saliva and urine samples was tested for anti-HCV using a modification of a serum anti-HCV kit. Western blot analysis was used as a confirmation method. Of the patients with liver diseases, 73 were anti-HCV-seropositive. Salivary and urinary anti-HCV could be detected in 66 (90%) and 36 (49%) of the anti-HCV-seropositive patients, respectively. The presence of anti-HCV in saliva or urine was not related to the severity of liver disease. All the anti-HCV-seronegative liver patients were negative for salivary anti-HCV and 22 (32%) had urinary anti-HCV. The patients with autoimmune diseases were all anti-HCV-seronegative. None had detectable salivary anti-HCV while 33 (63%) were positive for urinary anti-HCV. Western Blot analysis confirmed the presence of anti-HCV in all serum and saliva samples tested but only in 2/12 urine samples. The results suggest that saliva, but not urine, may serve as a substitute for serum for the determination of anti-HCV positivity.
“…The utility of urinary antibodies as a diagnostic tool has been investigated for certain viral diseases due to the inexpensive and non-invasive nature of sample collection 6 7 . During viral or bacterial infections, antibodies to immunoglobulins are excreted through urine, which have been found to be stable for considerable periods ( Table I ) 8 9 10 11 12 . The antibodies can be detected in urine using class-specific assays or Western blot 13 .…”
Antibody detection by serological methods gained a lot of interest in recent years and has become the backbone of virological diagnosis. Despite the detection of all five classes of immunoglobulins in urine, not much attention has been paid to the use of urine as a diagnostic sample to detect viral antibodies. Unlike venipuncture, this non-invasive mode of sample collection can help cover all age groups, especially paediatric and old age patients, where blood collection is difficult. Using urine as a sample is also economical and involves lesser risk in sample collection. The antibodies are found to be stable in urine at room temperature for a prolonged period, which makes the sample transport management easier as well. A few recent studies, have also shown that the detection limit of antibodies in urine is at par with serum or other clinical material. So, the ease in sample collection, availability of samples in large quantity and stability of immunoglobulins in urine for prolonged periods can make urine an ideal sample for viral diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.